Exploring glucagon receptor antagonism as a groundbreaking therapeutic approach for type 2 diabetes treatment through the dual hormone theory.
Comparing the effectiveness of triple therapy versus dual therapy for Type 2 Diabetes treatment, including clinical evidence and benefits.